Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Comparison of different miR-21 inhibitor chemistries in a cardiac disease model
Thomas Thum, Nelson Chau, Balkrishen Bhat, Shashi Kumar Gupta, Peter S. Linsley, Johann Bauersachs, Stefan Engelhardt
Thomas Thum, Nelson Chau, Balkrishen Bhat, Shashi Kumar Gupta, Peter S. Linsley, Johann Bauersachs, Stefan Engelhardt
View: Text | PDF
Letter

Comparison of different miR-21 inhibitor chemistries in a cardiac disease model

  • Text
  • PDF
Abstract

Authors

Thomas Thum, Nelson Chau, Balkrishen Bhat, Shashi Kumar Gupta, Peter S. Linsley, Johann Bauersachs, Stefan Engelhardt

×

Figure 1

Comparison of different miR-21 oligonucleotide inhibitors.

Options: View larger image (or click on image) Download as PowerPoint
Comparison of different miR-21 oligonucleotide inhibitors.
(A) Different...
(A) Different chemistries of miR-21 inhibitors (modifications of oligonucleotides are indicated with corresponding colors in the key). (B) miR-21 expression 48 hours and 19 days after treatment (21 days after TAC) with different miR-21 inhibitors (10–80 mg/kg). (C) Efficacy of different miR-21 inhibitors in a mouse model of left ventricular pressure overload (TAC) on left ventricular fibrosis formation, left ventricular mass, and ejection fraction. The different miR-21 oligonucleotide inhibitors have been applied twice on two consecutive days (#1 and #2). Original magnification, ×200. Ant-21, anti–miR-21; Chol, cholesterol. Data are mean ± SEM. *P < 0.05, **P < 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts